Compare AbbVie Inc (ABBV) vs Digital Realty Trust, Inc. (DLR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs Digital Realty Trust, Inc. — how do they compare? AbbVie Inc trades at $252.87 (market cap $449.91B), while Digital Realty Trust, Inc. trades at $175.76 (market cap $64.71B). The key difference: AbbVie Inc is far larger — about 7× Digital Realty Trust, Inc.'s market cap, and Digital Realty Trust, Inc. pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| ABBV | DLR | |
|---|---|---|
Market Cap | $449.91B | $64.71B |
Sector | Health | Real Estate |
52-Week High | $261.07 | $203.91 |
52-Week Low | $184.85 | $147.93 |
Enterprise Value | $513.38B | $82.23B |
Dividend Yield | 2.72% | 2.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $253.61, down 0.45% on the day, with strong technical momentum showing bullish moving averages and key support at $253. The company reported Q1 2026 EPS of $2.65, beating expectations, while revenue growth is supported by Skyrizi and Rinvoq offsetting Humira declines. Analysts maintain a bullish consensus with 68% buy ratings and a $266.33 price target, representing 5% upside potential.
The outlook remains positive with robust immunology portfolio performance and dividend growth, though risks include patent cliffs in the 2030s and competitive pressures. Current valuation metrics appear elevated with P/E at 124.83, requiring sustained earnings growth to justify premium multiples. The stock offers income appeal with consistent dividend payments while navigating portfolio transition.
DLR trades at $174.9, up 0.92% today, with a bearish technical signal but strong analyst buy consensus. The stock shows robust revenue growth, with 2025 revenue at $6.11B and net income margin of 21.73%, though valuation ratios like P/E of 46.07 appear elevated. Recent news highlights a $7.8B data center acquisition from Blackstone, expanding its hyperscale portfolio amid AI-driven demand.
Outlook remains positive with a consensus price target of $219.08, but risks include high debt levels, execution challenges from recent acquisitions, and competitive pressures. The stock offers growth exposure to data center infrastructure, supported by institutional confidence, yet investors should weigh valuation concerns against expansion potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Digital Realty Trust, Inc.
Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →
